PMC Articles for PubChem Compound (Select 9966051) - PMC

Result Filters

Links from PubChem Compound

Items: 1 to 20 of 113

<< First< Prev

Page of 6

Select item 109960881.

The ameliorating effect of Rutin on hepatotoxicity and inflammation induced by the daily administration of vortioxetine in rats

Mai M. Anwar, Ibrahim M. Ibrahim Laila

BMC Complement Med Ther. 2024; 24: 153. Published online 2024 Apr 5. doi: 10.1186/s12906-024-04447-9

PMCID:: PMC10996088

Abstract Article PDF–2.7M

Select item 109462442.

Emotional Blunting in Depression in the PREDDICT Clinical Trial: Inflammation-Stratified Augmentation of Vortioxetine With Celecoxib

Emma Sampson, Erhan Kavakbasi, Natalie T Mills, Hikaru Hori, K Oliver Schubert, Célia Fourrier, Bernhard T Baune

Int J Neuropsychopharmacol. 2024 Mar; 27(3): pyad066. Published online 2024 Mar 5. doi: 10.1093/ijnp/pyad066

PMCID:: PMC10946244

Abstract Article PDF–4.1M

Select item 109327633.

The efficacy of vortioxetine for the delusional disorder of cenesthopathy

Shinji Sato, Koubun Imai

Neuropsychopharmacol Rep. 2024 Mar; 44(1): 272–274. Published online 2023 Oct 4. doi: 10.1002/npr2.12384

PMCID:: PMC10932763

Abstract Article PDF–200K

Select item 109111684.

Vortioxetine Reverses Impairment of Visuospatial Memory and Cognitive Flexibility Induced by Degarelix as a Model of Androgen Deprivation Therapy in Rats

Alexandra M. Vaiana, Amber M. Asher, Karla Tapia, David A. Morilak

Neuroendocrinology. 2024 Mar; 114(3): 279–290. Published online 2023 Dec 16. doi: 10.1159/000535365

PMCID:: PMC10911168

Abstract Article

Select item 107202135.

Real-world clinical outcomes and treatment patterns in patients with MDD treated with vortioxetine: a retrospective study

Brandon T. McDaniel, Victor Cornet, Jeanne Carroll, Lambros Chrones, Joseph Chudzik, Jeanette Cochran, Shion Guha, Debra F. Lawrence, Maggie McCue, Sara Sarkey, Betty Lorenz, Jay Fawver

BMC Psychiatry. 2023; 23: 938. Published online 2023 Dec 13. doi: 10.1186/s12888-023-05439-8

PMCID:: PMC10720213

Abstract Article PDF–1.4M

Select item 106852166.

A 6-Month Open-Label Study of Vortioxetine among Cancer Patients with Major Depressive Disorder (MDD)

Chong Guan Ng, Aya Ahmed Abousheishaa, Sue Yin Low, Nor Zuraida Zainal, Kai Shin Thong, Azizul Bin Awaluddin, Tsui Huei Loo, Sapini Binti Yacob, Nik Ruzyanei Nik Jaafar, Nur Iwana Binti Abdul Taib, Nurul Ain Binti Mohamad Kamal, Fuad Ismail, Wan Zamaniah Wi

Asian Pac J Cancer Prev. 2023; 24(8): 2583–2591. doi: 10.31557/APJCP.2023.24.8.2583

PMCID:: PMC10685216

Abstract Article PDF–559K

Select item 105860317.

Activation of mTORC1 Signaling Cascade in Hippocampus and Medial Prefrontal Cortex Is Required for Antidepressant Actions of Vortioxetine in Mice

Wei-Yu Li, Tian-Shun Shi, Jie Huang, Yan-Mei Chen, Wei Guan, Bo Jiang, Cheng-Niu Wang

Int J Neuropsychopharmacol. 2023 Oct; 26(10): 655–668. Published online 2023 Apr 7. doi: 10.1093/ijnp/pyad017

PMCID:: PMC10586031

Abstract Article PDF–16M

Select item 105476958.

Effects of vortioxetine on hippocampal-related cognitive impairment induced in rats by androgen deprivation as a model of prostate cancer treatment

Alexandra M. Vaiana, Yidong Chen, Jonathan Gelfond, Teresa L. Johnson-Pais, Robin J. Leach, Chethan Ramamurthy, Ian M. Thompson, David A. Morilak

Transl Psychiatry. 2023; 13: 307. Published online 2023 Oct 3. doi: 10.1038/s41398-023-02600-5

PMCID:: PMC10547695

Abstract Article PDF–1.8M

Select item 105470069.

Bioequivalence Study of Vortioxetine Hydrobromide Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions

Wanjun Bai, Haojing Song, Yiting Hu, Xueyuan Zhang, Xiaoru Wang, Caihui Guo, Bo Qiu, Zhanjun Dong

Drug Des Devel Ther. 2023; 17: 3035–3046. Published online 2023 Sep 29. doi: 10.2147/DDDT.S428771

PMCID:: PMC10547006

Abstract Article PDF–2.8M

Select item 1029432910.

Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with major depressive disorder: a PatientsLikeMe survey

Subhara Raveendran, Deepshikha Singh, Mary C. Burke, Alicia H. McAuliffe-Fogarty, Sagar V. Parikh, Roger S. McIntyre, Anit Roy, Michael Martin, Lambros Chrones, Mark G. A. Opler, Chris Blair, Maggie McCue

BMC Psychiatry. 2023; 23: 464. Published online 2023 Jun 26. doi: 10.1186/s12888-023-04922-6

PMCID:: PMC10294329

Abstract Article PDF–2.1M

Select item 1028914511.

Effectiveness and Safety of Vortioxetine for the Treatment of Major Depressive Disorder in the Real World: A Systematic Review and Meta-Analysis

Zejun Li, Shouhuan Liu, Qiuxia Wu, Jing Li, Qian Yang, Xin Wang, Pu Peng, Qianjin Wang, Yueheng Liu, Manyun Li, Yuzhu Hao, Huixue Xu, Li He, Yunfei Wang, Shubao Chen, Tieqiao Liu

Int J Neuropsychopharmacol. 2023 Jun; 26(6): 373–384. Published online 2023 Apr 27. doi: 10.1093/ijnp/pyad018

PMCID:: PMC10289145

Abstract Article PDF–5.0M

Select item 1026494612.

Does ethnicity impact CYP2D6 genotype–phenotype relationships?

Trine Frederiksen, Johan Areberg, Ellen Schmidt, Tore Bjerregaard Stage, Kim Brøsen

Clin Transl Sci. 2023 Jun; 16(6): 1012–1020. Published online 2023 Mar 23. doi: 10.1111/cts.13506

PMCID:: PMC10264946

Abstract Article PDF–4.2M

Select item 1020792213.

Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy

Marco Di Nicola, Bernardo Dell’Osso, Ilaria Peduto, Riccardo Cipelli, Anna Cristina Pugliese, Maria Salvina Signorelli, Antonio Ventriglio, Giovanni Martinotti

Curr Neuropharmacol. 2023 Mar 8; 21(3): 727–739. Published online 2023 Mar 8. doi: 10.2174/1570159X20666220411092813

PMCID:: PMC10207922

Abstract Article PDF–3.7M

Select item 1007634214.

Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study

Susana S Almeida, Michael Cronquist Christensen, Kenneth Simonsen, Michael Adair

J Psychopharmacol. 2023 Mar; 37(3): 279–288. Published online 2022 Nov 15. doi: 10.1177/02698811221132468

PMCID:: PMC10076342

Abstract Article PDF–637K

Select item 1007633615.

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder

Houman Rashidian, Mehala Subramaniapillai, Caroline Park, Orly Lipsitz, Hannah Zuckerman, Bing Cao, Yena Lee, Hartej Gill, Roger Nelson Rodrigues, Joshua D. Di Vincenzo, Michelle Iacobucci, Saja Jaberi, Joshua D. Rosenblat, Roger S. McIntyre, Rodrigo B. Mansur

J Psychopharmacol. 2023 Mar; 37(3): 313–317. Published online 2022 Nov 15. doi: 10.1177/02698811221132473

PMCID:: PMC10076336

Abstract Article PDF–687K

Select item 1004749516.

Broad Serotonergic Actions of Vortioxetine as a Promising Avenue for the Treatment of L-DOPA-Induced Dyskinesia

Carla Budrow, Kayla Elder, Michael Coyle, Ashley Centner, Natalie Lipari, Sophie Cohen, John Glinski, N’Senga Kinzonzi, Emily Wheelis, Grace McManus, Fredric Manfredsson, Christopher Bishop

Cells. 2023 Mar; 12(6): 837. Published online 2023 Mar 8. doi: 10.3390/cells12060837

PMCID:: PMC10047495

Abstract Article PDF–12M

Select item 991667917.

Therapeutic Potential and Limitation of Serotonin Type 7 Receptor Modulation

Kouji Fukuyama, Eishi Motomura, Motohiro Okada

Int J Mol Sci. 2023 Feb; 24(3): 2070. Published online 2023 Jan 20. doi: 10.3390/ijms24032070

PMCID:: PMC9916679

Abstract Article PDF–710K

Select item 990509918.

Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes

Marco Di Nicola, Maria Pepe, Silvia Montanari, Maria Chiara Spera, Isabella Panaccione, Alessio Simonetti, Gabriele Sani

Eur Neuropsychopharmacol. 2023 May; 70: 21–28. Published online 2023 Feb 8. doi: 10.1016/j.euroneuro.2023.02.006

PMCID:: PMC9905099

Abstract Article PDF–559K

Select item 989028819.

Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma

Sergio De Filippis, Ginevra Lombardozzi, Marta Matrone, Emanuela Amici, Giada Trovini, Filippo Perrini, Alessandro Di Giovanni, Valeria Giovanetti, Georgios D. Kotzalidis

Curr Neuropharmacol. 2022 Nov 15; 20(12): 2393–2407. Published online 2022 Nov 15. doi: 10.2174/1570159X20666220310122849